Ypsomed Holding AG 0QLQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 0QLQ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 201.17
- Price/Sales
- 4.31
- Dividend Yield (Trailing)
- 0.80%
- Dividend Yield (Forward)
- 0.41%
- Total Yield
- 0.80%
Company Profile
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company’s sales, respectively.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,200
- Website
- https://www.ypsomed.com
Comparables
Valuation
|
Metric
|
0QLQ
|
MOVE
|
VBSN
|
|---|---|---|---|
Price/Earnings (Normalized) | 201.17 | 41.93 | 22.38 |
Price/Book Value | 4.79 | 7.19 | 2.27 |
Price/Sales | 4.31 | 4.45 | 2.32 |
Price/Cash Flow | 17.52 | 19.65 | 17.23 |
Price/Earnings
0QLQ
MOVE
VBSN
Financial Strength
|
Metric
|
0QLQ
|
MOVE
|
VBSN
|
|---|---|---|---|
Quick Ratio | 0.46 | 0.82 | 3.89 |
Current Ratio | 0.77 | 2.33 | 4.42 |
Interest Coverage | 23.67 | 9.58 | 887.05 |
Quick Ratio
0QLQ
MOVE
VBSN
Profitability
|
Metric
|
0QLQ
|
MOVE
|
VBSN
|
|---|---|---|---|
Return on Assets (Normalized) | 8.39% | 8.23% | 8.59% |
Return on Equity (Normalized) | 13.21% | 17.55% | 10.63% |
Return on Invested Capital (Normalized) | 11.30% | 13.31% | 9.97% |
Return on Assets
0QLQ
MOVE
VBSN
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Pmtjygyxsc | Lccf | $133.1 Bil | |
BDX
| Becton Dickinson & Co | Ynwstrwt | Kjlkd | $66.9 Bil | |
ALC
| Alcon Inc | Jpjrgkqk | Ppqbfh | $38.9 Bil | |
RMD
| ResMed Inc | Plprxjwwb | Lvqpw | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Vsqkjdjsn | Fvx | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Mrdrbwhhh | Qxrvf | $26.4 Bil | |
BAX
| Baxter International Inc | Bscspngc | Yclvsq | $20.4 Bil | |
HOLX
| Hologic Inc | Vxsypgvmz | Cbmqnhk | $17.8 Bil | |
COO
| The Cooper Companies Inc | Gcbqvddd | Tnfxn | $17.7 Bil | |
TFX
| Teleflex Inc | Bjrj | Mqkw | $9.7 Bil |